Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Sangamo BioSciences, Inc. (SGMO)

« Back to company index

SGMO Chatter Timeline

Stock Ticker for SGMO

Most Active Tweeters for SGMO

UserTweets
@_B_I_O_T_E_C_H_ 30
@Gambiste1 14
@BiotechAnalysst 11
@mchilberg 9
@biotech_junkie 9

Recent Tweets for SGMO

BigHopeBigWish @BigHopeBigWish
@_B_I_O_T_E_C_H_ why shit $SGMO big drop today? thx
January 17th 2020, 6:01pm
Aesculapius1898 @Aesculapius1898
RT @_B_I_O_T_E_C_H_: $SGMO the rise of genome editing https://t.co/oxgfpJ8Jep?
January 17th 2020, 6:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$SGMO the rise of genome editing https://t.co/oxgfpJ8Jep?
January 17th 2020, 6:01pm
EVgirl66 @EVgirl66
RT @JustTradingHoy: $SGMO @sangamoTx did you #FireSandy yet? Again don't send him to another investor conference again. When he goes, h…
January 17th 2020, 5:01pm
osok762 @osok762
RT @TomSilver39: WF:" Biotech Management Meetings Reinforce Positive Sector Outlook/Top Picks: $SGMO Key driver: SB-525 Hemophilia A data,…
January 17th 2020, 2:01pm
JustTradingHoy @JustTradingHoy
$SGMO @sangamoTx did you #FireSandy yet? Again don't send him to another investor conference again. When he goe… https://t.co/ucW7XHWbAS
January 17th 2020, 1:01pm
TranscriptDaily @TranscriptDaily
Sangamo Therapeutics $SGMO Upgraded to Strong-Buy by Zacks Investment Research https://t.co/sbTJ9vQssq
January 17th 2020, 1:01pm
stocknewstimes @stocknewstimes
Sangamo Therapeutics $SGMO Stock Rating Upgraded by Zacks Investment Research https://t.co/GVr3XJAARb
January 17th 2020, 1:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @mchilberg: I'll play a little "what if" . What if $SGMO proves validation of cDNA platform with P I/II data for #Fabry and are able to…
January 17th 2020, 1:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @dteb16: ?READ?THIS?SLOWLY? ???? $SGMO
January 17th 2020, 1:01pm
mchilberg @mchilberg
I'll play a little "what if" . What if $SGMO proves validation of cDNA platform with P I/II data for #Fabry and ar… https://t.co/PceBOnw10I
January 17th 2020, 12:01pm
MitchellReed09 @MitchellReed09
RT @MaxPowerNGS: @mchilberg Gene therapy is not core for $SGMO. Even if their vector and construct libraries are best in class (which HemoA…
January 17th 2020, 11:01am
jwil408 @jwil408
RT @TheMarketsDaily: Sangamo Therapeutics $SGMO Stock Rating Upgraded by Zacks Investment Research https://t.co/mDQhfbkex0
January 17th 2020, 11:01am
TomSilver39 @TomSilver39
WF:" Biotech Management Meetings Reinforce Positive Sector Outlook/Top Picks: $SGMO Key driver: SB-525 Hemophilia A… https://t.co/UjXRpMLOyi
January 17th 2020, 10:01am
ThomasPhilipp6 @ThomasPhilipp6
RT @portefeuillefun: Bought 10k $SGMO at $8.66, now 50k #vssporte shares.
January 17th 2020, 10:01am
BehaviorFin @BehaviorFin
$8.6 support for $SGMO
January 17th 2020, 10:01am
portefeuillefun @portefeuillefun
Bought 10k $SGMO at $8.66, now 50k #vssporte shares.
January 17th 2020, 10:01am
_TJHawkins @_TJHawkins
Does $SGMO sp make sense to anyone????? Other than an opportunity to get a great stock cheaper every day?
January 17th 2020, 10:01am
portefeuillefun @portefeuillefun
Bought 6k $SGMO at $8.85, now 40k #vssporte shares.
January 17th 2020, 9:01am
Biotech2050 @Biotech2050
RT @dteb16: So, again, if everyone sadly agrees that $SGMO entire market cap is just HemA SB525 + Cash, and $0 for the rest of the company.…
January 17th 2020, 9:01am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @dteb16: Even slower the third time.... "[FDA]...has been very creative in allowing us [to get to] accelerated approval...” $SGMO
January 17th 2020, 9:01am
dteb16 @dteb16
So, again, if everyone sadly agrees that $SGMO entire market cap is just HemA SB525 + Cash, and $0 for the rest of… https://t.co/L2yqxaw3BH
January 17th 2020, 9:01am
dteb16 @dteb16
Even slower the third time.... "[FDA]...has been very creative in allowing us [to get to] accelerated approval...” $SGMO
January 17th 2020, 9:01am
dteb16 @dteb16
Repeat this part... “The agency, I think, has been very creative in allowing us to do #accelerated #approval by renal biopsy...” $SGMO
January 17th 2020, 9:01am
dteb16 @dteb16
?READ?THIS?SLOWLY? ???? $SGMO https://t.co/wNaiwSYMUH
January 17th 2020, 9:01am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @BehaviorFin: This seems to be one of the most important piece of information out of #JPM $SGMO conference. One of the issues on past cl…
January 17th 2020, 8:01am
Gambiste1 @Gambiste1
RT @Aesculapius1898: @wyv_123 $sgmo might be an interesting partner for Lilly in Immunology and Neurology
January 17th 2020, 6:01am
ZolmaxNews @ZolmaxNews
Zacks: Analysts Expect Sangamo Therapeutics Inc $SGMO Will Announce Earnings of -$0.31 Per Share https://t.co/ego628tJht
January 17th 2020, 5:01am
TickerReport @TickerReport
-$0.31 Earnings Per Share Expected for Sangamo Therapeutics Inc $SGMO This Quarter https://t.co/cJdvvDjuHw
January 17th 2020, 5:01am
BehaviorFin @BehaviorFin
This seems to be one of the most important piece of information out of #JPM $SGMO conference. One of the issues on… https://t.co/7PaY4rC8oQ
January 17th 2020, 5:01am
subach @subach
$SGMO T-reg program still speculative. Idea of just needing to localize T-regs to tissues specific to disease seems… https://t.co/2EWv9w8SaG
January 17th 2020, 4:01am
subach @subach
$SGMO ZFN editing remains in doubt, not dig on the Co! GE is hard, no one has demonstrated it robustly outside of t… https://t.co/awpgcD3OhC
January 17th 2020, 4:01am
YrbnycC @YrbnycC
RT @BehaviorFin: How would you rate/consider $SGMO after #JPM presentation yesterday? How would you consider investing in the stock vs $B…
January 17th 2020, 3:01am
BehaviorFin @BehaviorFin
How would you rate/consider $SGMO after #JPM presentation yesterday? How would you consider investing in the stoc… https://t.co/farVPVSnid
January 17th 2020, 3:01am
vtorion @vtorion
@SangamoTx $sgmo You need to set your roadmap to funding that doesn’t include near term dilution - that’s the big… https://t.co/kaR4LkYgKe
January 16th 2020, 6:01pm
dakotafinancial @dakotafinancial
Sangamo Therapeutics $SGMO Upgraded to “Strong-Buy” by Zacks Investment Research https://t.co/2mZ6EbTcqy
January 16th 2020, 5:01pm
TheMarketsDaily @TheMarketsDaily
Sangamo Therapeutics $SGMO Stock Rating Upgraded by Zacks Investment Research https://t.co/mDQhfbkex0
January 16th 2020, 5:01pm
Gambiste1 @Gambiste1
RT @mchilberg: Commented on $SGMO - Sangamo 2020: Gene Therapy Plus Optionality Equals Opportunity. https://t.co/SRC3Hw4iyg
January 16th 2020, 5:01pm
mchilberg @mchilberg
Commented on $SGMO - Sangamo 2020: Gene Therapy Plus Optionality Equals Opportunity. https://t.co/SRC3Hw4iyg
January 16th 2020, 5:01pm
heyjt55 @heyjt55
RT @yusufhameed: $SGMO at #JPM2020 was pretty solid. All the money coming into Sangamo bank account from Pfizer in 2020 is impressive, can'…
January 16th 2020, 4:01pm
yusufhameed @yusufhameed
$SGMO at #JPM2020 was pretty solid. All the money coming into Sangamo bank account from Pfizer in 2020 is impressiv… https://t.co/0qhy31B0hs
January 16th 2020, 4:01pm
ChartMill @ChartMill
$SGMO has a Current Ratio of 4.77, so it is financially healthy and has no problem in meeting its obligations.… https://t.co/HheIVbKcmp
January 16th 2020, 4:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: $SGMO Hemophilia A " program alone is worth more than the market cap " #JPM20 https://t.co/9Cyw1V9uQZ
January 16th 2020, 4:01pm
YMuer @YMuer
RT @_B_I_O_T_E_C_H_: $SGMO JPMorgan Breakout Session: Patient 9 factor levels are recovering ! #JPM20 https://t.co/IIoXyPRiRu
January 16th 2020, 3:01pm
BiotechAnalysst @BiotechAnalysst
RT @mchilberg: Interesting to hear $SGMO say they would be done with #Genetherapy after PKU when they showed discovery activity just 3 wks…
January 16th 2020, 3:01pm
BiotechAnalysst @BiotechAnalysst
RT @_B_I_O_T_E_C_H_: $SGMO talking #AA on #Fabry with a creative #FDA " The agency, I think, has been very creative in allowing us to do #…
January 16th 2020, 3:01pm
BiotechAnalysst @BiotechAnalysst
RT @_B_I_O_T_E_C_H_: JPMorgan Breakout Session $SGMO #FABRY "per discussions with the #FDA, 6-month Gb3 kidney levels assessed by biopsy i…
January 16th 2020, 3:01pm
BiotechAnalysst @BiotechAnalysst
RT @_B_I_O_T_E_C_H_: $SGMO CEO says "We get $300 million between the IND transfer and the first commercial patient. And then we get betwee…
January 16th 2020, 3:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$SGMO talking #AA on #Fabry with a creative #FDA " The agency, I think, has been very creative in allowing us to d… https://t.co/JKtHDrg1VT
January 16th 2020, 3:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
JPMorgan Breakout Session $SGMO #FABRY "per discussions with the #FDA, 6-month Gb3 kidney levels assessed by biops… https://t.co/ZqFJtQvlVF
January 16th 2020, 3:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.